Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03777384 · ClinicalTrials.gov registry record
EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers
A clinical trial of Oropharyngeal Cancer, sponsored by Sanford Health.
- Active
- Registry status
- 75
- Enrollment target
- 2
- Study locations
NCT03777384: Active study of Oropharyngeal Cancer, sponsored by Sanford Health.
NCT03777384 is a study of Oropharyngeal Cancer that is active but no longer recruiting, run by Sanford Health. The registered enrollment target is 75 participants, below the 187-participant average among 25 other Oropharyngeal Cancer trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03777384, a study of Oropharyngeal Cancer, is active but no longer recruiting, sponsored by Sanford Health.
- ACTIVE NOT RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective, observational study evaluating the durability of local/regional control of previously published de-escalated radiotherapy protocols for patients with P16 positive oropharynx cancers who have minimal nicotine exposure who are not current uses (\< 10 pack year smoking history; \< 10 year history of any nicotine product \[electronic cigarette, chewing tobacco\]). Quality of Life measures will also be collected.
Primary Outcome
Number of participants who remain disease free from the end of treatment to 5 years after treatment.
Conditions Studied
Study Locations (2)
North Dakota
- Sanford Roger Maris Cancer Center - Fargo
South Dakota
- Sanford Edith Cancer Center - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-10-12 |
| Est. Completion | 2026-12 |
What the registry record for NCT03777384 still lists
NCT03777384 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 187-participant average among 25 other Oropharyngeal Cancer trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Oropharyngeal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03777384 reports a single indexed study location in North Dakota, South Dakota.
Frequently Asked Questions
What is clinical trial NCT03777384 about?
NCT03777384 is a clinical study titled "EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers". A prospective, observational study evaluating the durability of local/regional control of previously published de-escalated radiotherapy protocols for patients with P16 positive oropharynx cancers who have minimal nicotine exposure who are not current uses (\< 10 pack year smoking history; \< 10 yea...
What is the current status of trial NCT03777384?
This trial is currently active not recruiting. The enrollment target is 75 participants. The study started on 2018-10-12. Estimated completion is 2026-12.
What conditions does trial NCT03777384 study?
This clinical trial studies the following conditions: Oropharyngeal Cancer.
Who is sponsoring clinical trial NCT03777384?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03777384 being conducted?
This trial has 2 study locations across North Dakota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oropharyngeal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03777384's enrollment target sits among peer trials
75 13th of 25 higher than 12 of 25 other Oropharyngeal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Oropharyngeal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
RECRUITING
-
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
RECRUITING · Phase 2
-
BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
RECRUITING · Phase 2
-
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
RECRUITING · Phase 2
-
Liposomal Bupivacaine and Transoral Robotic Surgery
RECRUITING
-
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI